Emcure Pharmaceuticals reports Q1 FY26 consolidated PAT higher at Rs. 206.95 Cr
News

Emcure Pharmaceuticals reports Q1 FY26 consolidated PAT higher at Rs. 206.95 Cr

Emcure Pharmaceuticals has reported total income of Rs. 2,104.23 crores during the period ended June 30, 2025

  • By IPP Bureau | August 11, 2025

Emcure Pharmaceuticals Limited has reported consolidated financial results for the period ended June 30, 2025. 

Emcure Pharmaceuticals has posted net profit of Rs. 206.95 crores for the period ended June 30, 2025 as against net profit of Rs. 188.95 crores for the period ended March 31, 2025. The company posted net profit of Rs. 144.08 crores for the period ended June 30, 2024. 

Emcure Pharmaceuticals has reported total income of Rs. 2,104.23 crores during the period ended June 30, 2025 as compared to Rs. 2,120.69 crores during the period ended March 31, 2025. The company reported total income of Rs.1, 838.22 crores during the period ended June 30, 2024.

Upcoming E-conference

Other Related stories

Startup

Digitization